Patient engagement is a crucial responsibility of any gene therapy company if they’re serious about progressing safe, effective, and meaningful therapies to patients. The 4th Gene Therapy Patient Engagement Summit is returning in 2024, sitting at the unique interface of patient engagement and gene therapy, from embarking on first in-human trials through to commercial therapeutics.

Delve into key challenges including engaging in R&D and managing expectations of gene therapies, language and nomenclature used to educate on what gene therapies are and what it means to participate in a clinical trial, outlining informed consent to support clinical trial enrollment, and understanding the latest regulatory requirements to effectively demonstrate that these transformative therapies are meaningful to patients.

Join 80+ patient advocacy and engagement professionals from gene therapy companies and patient advocacy groups to gain actionable insights that you can immediately implement into your own gene therapy programs. Unite with the leading voices in this community to develop solutions to the challenges that are unique to the gene therapy space.

To learn more and discover the full agenda, visit the official event website at genetherapy-patient-engagement.com